Medivir: Candidate Drug Designated within the Tibotec ... (Chronic Hepatitis C)

Medivir: Candidate Drug Designated within the Tibotec ...
Genetic Engineering News, NY - Dec 29, 2005The Hepatitis C Virus (HCV) collaboration with Tibotec Pharmaceuticals Ltd has recently designated a Candidate Drug (CD). The aim ...

MedMira Granted HCV Patent in Europe
ag-IP-news Agency, Jordan - 5 hours agodiagnostic solutions, announced on Wednesday that it has been granted a patent forthe HCV Mosaic Antigen by the European Patent Office. ...

Pfizer releases further details of liver toxicity in maraviroc ...
Aidsmap, UK - Dec 5, 2005... The patient was HIV and HCV seropositive, HCV RNA negative, with radiographic evidence of underlying hepatic steatosis at time of screening into study. ...

Hepatocellular Carcinoma Treatment Options Remain Limited, but New ...
DG News - Dec 20, 2005... Hepatocellular carcinoma often occurs in advanced hepatitis C (HCV) and now afflicts an estimated 1 million individuals worldwide. ...